Anti-tumor effect of combining CC chemokine 22 and an anti-CD25 antibody on myeloma cells implanted subcutaneously into mice.

MLA

Cho, Seiji, et al. “Anti-Tumor Effect of Combining CC Chemokine 22 and an Anti-CD25 Antibody on Myeloma Cells Implanted Subcutaneously into Mice.” Molecular Medicine Reports, vol. 2, no. 5, Sept. 2009, pp. 773–77. EBSCOhost, https://doi.org/10.3892/mmr_00000171.

APA

Cho, S., Koizumi, K., Takeno, N., Kato, S., Yamada, M., Hashimoto, I., Sakurai, H., Tsukada, K., & Saiki, I. (2009). Anti-tumor effect of combining CC chemokine 22 and an anti-CD25 antibody on myeloma cells implanted subcutaneously into mice. Molecular Medicine Reports, 2(5), 773–777. https://doi.org/10.3892/mmr_00000171

Chicago

Cho, Seiji, Keiichi Koizumi, Nobuhiro Takeno, Shinichiro Kato, Miyuki Yamada, Isaya Hashimoto, Hiroaki Sakurai, Kazuhiro Tsukada, and Ikuo Saiki. 2009. “Anti-Tumor Effect of Combining CC Chemokine 22 and an Anti-CD25 Antibody on Myeloma Cells Implanted Subcutaneously into Mice.” Molecular Medicine Reports 2 (5): 773–77. doi:10.3892/mmr_00000171.